BenevolentAI
a novel target for data support the rationale for as a novel target for regulates signal transduction by is in derived colon and colonic mucosa samples whilst which makes is down regulated reduced levels of correlate with increased in colonic mucosa is in and its expression inversely correlates to disease severity is well studied in disorders but not in in with zero linkage to was experimentally validated as a novel target using biopsies from pharmacotherapy resistant patients in release from samples reduced with inhibition | BenevolentAI
Company
Deck Type
Deck date
December 2021
Slide
26 of 42
Similar slides by BenevolentAI
Results
March 2023
Investor Presentation
October 2022
Investor Day
September 2022
Investor Presentation
June 2022
Related slides by other companies
Results
December 2022
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io